AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 DEC 1 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced that FluMist (Influenza Virus Vaccine Live, Intranasal) has been included in the federal government's Vaccines for Children (VFC) program as an alternative to the injectable flu vaccine beginning in the 2005-2006 influenza season.
As a result of this vote by the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP), healthy children ages 5 to 18 years who meet the eligibility requirements of the VFC program may receive FluMist at no cost next season.
"The addition of FluMist to the VFC program is an important step in ensuring that more children have access to the benefits of newly recommended vaccines," said Caroline York, vice president, government affairs and reimbursement, at MedImmune. "We are pleased to join in the nationwide endeavor to help keep children and families healthy during the influenza season."
For the 2004-2005 influenza season, the CDC has encouraged the use of intranasally administered, live, attenuated influenza vaccine (FluMist), if available, for healthy, non-pregnant individuals ages 5 to 49 years, including healthcare workers (except those who care for severely immunocompromised patients in special care units) and individuals caring for children younger than 6 months.
In an effort to increase childhood immunization levels, the VFC program provides federally purchased vaccines to children who are enrolled in Medicaid, or who are uninsured, underinsured, American Indian or Alaskan Native. Many ...